Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Zevra Therapeutics (ZVRA) Asset Utilization Ratio (2016 - 2025)

Zevra Therapeutics (ZVRA) has disclosed Asset Utilization Ratio for 8 consecutive years, with 0.38 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio rose 200.52% year-over-year to 0.38, compared with a TTM value of 0.38 through Dec 2025, up 200.52%, and an annual FY2025 reading of 0.46, up 241.51% over the prior year.
  • Asset Utilization Ratio was 0.38 for Q4 2025 at Zevra Therapeutics, up from 0.32 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.46 in Q1 2021 and bottomed at 17.62 in Q3 2022.
  • Average Asset Utilization Ratio over 5 years is 0.69, with a median of 0.17 recorded in 2024.
  • The sharpest move saw Asset Utilization Ratio crashed 8648.65% in 2022, then soared 200.52% in 2025.
  • Year by year, Asset Utilization Ratio stood at 0.21 in 2021, then crashed by 40.59% to 0.13 in 2022, then soared by 39.99% to 0.18 in 2023, then dropped by 27.59% to 0.13 in 2024, then skyrocketed by 200.52% to 0.38 in 2025.
  • Business Quant data shows Asset Utilization Ratio for ZVRA at 0.38 in Q4 2025, 0.32 in Q3 2025, and 0.29 in Q2 2025.